Validation of an Image-Based 3D Natural Killer Cell Mediated Cytotoxicity Assay
Poster Oct 13, 2017
Brad Larson1, Lubna Hussain2 and Jenny Schroeder3
Natural killer (NK) cells are a type of cytotoxic lymphocyte found in peripheral blood that play a role in host defense and immune regulation. Most recently, NK cells have become of particular interest in the field of immunotherapy due to their potential to target and destroy specific cancer cells, while leaving non-target healthy cells intact. The anti-cancer activity of NK cells has been shown to be associated with a better prognosis in several cancers such as colorectal cancer1, non-small cell lung cancer2, and clear cell renal cell carcinoma3.
In order to properly study the interaction between NK cells and target tumor cells, an appropriate in vitro model system must be established. However, much of the data published to date has used cancer cells plated as a two dimensional (2D) monolayer on the bottom of microplate wells. A growing amount of data has shown that cells cultured in this manner lack the cell:cell and cell:matrix communication, metabolic gradients, and polarity demonstrated in vivo4. The ability to perform matrix infiltration studies is also eliminated with the use of 2D cell culture. By embedding cancer cells into a three dimensional (3D) matrix and allowing the formation of tumor spheroids, or tumoroids, the shortcomings of using 2D cultured cells can be overcome as communication networks and cellular gradients observed within in vivo tumors are reestablished.
With the incorporation of 3D cultured cells, however, traditional methods to monitor target and NK cell interactions, and subsequent target cell killing can become problematic. Microplate reader assays designed to detect signal from cell monolayers lack the sensitivity to quantify signal from spheroids surrounded by non-cell containing areas in the well with no signal generation. By incorporating microscopy-based detection and cellular analysis, signal emanating solely from spheroids is quantified, providing a highly robust method to detect induced toxicity within target cancer cells.
Here we describe a novel 3D NK cell mediated cytotoxicity (CMC) assay. HCT116 colorectal cancer cells were embedded within a collagen hydrogel of defined concentration and thickness, mimicking in vivo extracellular matrix (ECM). Following cell propagation to create tumoroids within the matrix, HCT116 and NK cells were labeled with individual cell tracking dyes, followed by NK cell addition. Fluorescent apoptosis and necrosis probes were also added to track cytotoxic events within the tumoroids. Cellular imaging and analysis were performed at regular intervals over a seven day period to monitor NK cell binding to the tumoroids and induced apoptosis and necrosis of the HCT116 cells making up each tumoroid. Experimental testing validated that the combined assay technique provides a sensitive, accurate, and repeatable in vitro method to determine the ability of NK cells to target and kill tumor cells.
P450 Induction in Cryopreserved Hepatocytes from PXR and CAR Nuclear Receptor Knock-out RatsPoster
The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that regulate the expression of phase I (cytochrome P450s), phase II metabolizing enzymes and transporter genes in response to xenobiotics, including prescription drugs.READ MORE
Mass Spectrometry: From Imaging to Metabolic NetworksPoster
We show that network analysis of co-localized ions from mass spectrometry imaging data provides a detailed chemo-spatial insight into the metabolic heterogeneity of tumor. Furthermore, module preservation analysis between colorectal cancer patients with and without metastatic recurrence suggests hypotheses on the nature of the different local metabolic pathways.READ MORE
Treatment Options for Chronic Parvovirus Viremia in Pediatric Heart Transplant Patients in a Tertiary Care CenterPoster
This abstract discusses three cases of pediatric heart transplant patients who suffered from parvovirus (B19) infection. Of these patients, two ( B & C) responded well to standard intravenous Ig therapy. Patient A however, did not respond to standard treatment and was begun on subcutaneous Ig, which effectively diminished his viral load. Thus, subcutaneous Ig infusions might serve as a second line treatment for transplant patients with parvovirus who do not respond well to the standard approach.READ MORE